YAP mediates resistance to EGF-induced apoptosis in EGFR-mutated non-small cell lung cancer cells.

Mechanisms underlying the growth and survival of non-small cell lung cancer (NSCLC) cells positive for activating mutations of the epidermal growth factor receptor gene (EGFR) have remained unclear. We here examined the functional relation between such mutant forms of EGFR and Yes-associated protein (YAP), a transcriptional coactivator of the Hippo signaling pathway that regulates cell proliferation and survival. Under the condition of serum deprivation, epidermal growth factor (EGF) induced activation of YAP in NSCLC cell lines positive for mutated EGFR but not in those wild type (WT) for EGFR. Similar EGF-induced activation of YAP was apparent in A549 lung cancer cells forcibly expressing mutant EGFR but not in those overexpressing the WT receptor. Furthermore, EGF induced apoptotic cell death in serum-deprived A549 cells overexpressing the WT form of EGFR but not in those expressing mutant EGFR, and knockdown of YAP rendered the latter cells sensitive to this effect of EGF. Our results thus suggest that activation of YAP mediates resistance of EGFR -mutated NSCLC cells to EGF-induced apoptosis and thereby contributes specifically to the survival of such cells. • Specific survival signals for EGFR mutated (MT) NSCLC have remained unknown. • EGF activates YAP in EGFR -MT NSCLC cells but not in those wild type (WT) for EGFR. • EGFR-WT cells, but not EGFR -MT cells, are sensitive to EGF-induced apoptosis. • This resistance of EGFR -MT cells is dependent on YAP. [ABSTRACT FROM AUTHOR]